Last reviewed · How we verify

Tumescent Lidocaine and Epinephrine

Jeffrey Alan Klein, MD · Phase 2 active Small molecule

Tumescent Lidocaine and Epinephrine is a Small molecule drug developed by Jeffrey Alan Klein, MD. It is currently in Phase 2 development. Also known as: Tumescent Local Anesthesia.

At a glance

Generic nameTumescent Lidocaine and Epinephrine
Also known asTumescent Local Anesthesia
SponsorJeffrey Alan Klein, MD
ModalitySmall molecule
PhasePhase 2

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Tumescent Lidocaine and Epinephrine

What is Tumescent Lidocaine and Epinephrine?

Tumescent Lidocaine and Epinephrine is a Small molecule drug developed by Jeffrey Alan Klein, MD.

Who makes Tumescent Lidocaine and Epinephrine?

Tumescent Lidocaine and Epinephrine is developed by Jeffrey Alan Klein, MD (see full Jeffrey Alan Klein, MD pipeline at /company/jeffrey-alan-klein-md).

Is Tumescent Lidocaine and Epinephrine also known as anything else?

Tumescent Lidocaine and Epinephrine is also known as Tumescent Local Anesthesia.

What development phase is Tumescent Lidocaine and Epinephrine in?

Tumescent Lidocaine and Epinephrine is in Phase 2.

Related